Cubist Systematic Strategies, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$40,899
-0.6%
35,258
+29.4%
0.00%
Q1 2023$41,129
-95.3%
27,238
-92.2%
0.00%
-100.0%
Q4 2022$876,203
-43.3%
350,481
-4.2%
0.01%
-44.4%
Q3 2022$1,544,000
+1197.5%
365,775
+754.6%
0.01%
+800.0%
Q2 2022$119,000
-81.6%
42,800
-62.1%
0.00%
-80.0%
Q1 2022$646,000
-39.7%
112,997
-3.8%
0.01%
-50.0%
Q4 2021$1,072,000
+15.0%
117,431
+34.8%
0.01%
-16.7%
Q3 2021$932,000
+62.4%
87,145
+135.5%
0.01%
+100.0%
Q2 2021$574,000
-6.4%
37,004
-2.2%
0.01%
-25.0%
Q1 2021$613,000
+246.3%
37,819
+353.4%
0.01%
+300.0%
Q4 2020$177,000
-5.3%
8,342
-33.8%
0.00%
-33.3%
Q3 2020$187,000
-19.4%
12,609
-20.2%
0.00%
-25.0%
Q2 2020$232,000
-88.0%
15,801
-90.4%
0.00%
-92.3%
Q1 2020$1,935,000
-23.7%
164,859
+52.7%
0.05%
+13.0%
Q4 2019$2,537,000
+612.6%
107,969
+641.2%
0.05%
+283.3%
Q1 2019$356,000
+5.3%
14,566
+36.3%
0.01%
-33.3%
Q3 2018$338,000
+123.8%
10,690
+174.7%
0.02%
+125.0%
Q2 2018$151,000
-52.1%
3,891
-77.6%
0.01%
-52.9%
Q4 2017$315,000
+67.6%
17,395
+125.3%
0.02%
+70.0%
Q3 2015$188,000
+347.6%
7,722
+166.3%
0.01%
+400.0%
Q1 2015$42,0002,9000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders